JLL Partners related stories
All articles and analysis
Atlantic-Pacific Capital Adds Brian WadeAtlantic-Pacific Capital has added Brian Wade as a partner. Wade will work with institutional investors in the Mid-Atlantic and Southeast United States, including public and corporate pension plans, endowments, foundations, financial institutions, fund-of-funds and family offices, the firm said. He was previously a Managing Director in Credit Suisse Asset Management's institutional distribution group.
- Wade Joins Atlantic-Pacific Capital
Brian Wade has joined Atlantic-Pacific Capital as a partner. He will work with institutional investors in the Mid-Atlantic and Southeast United States. Wade was previously an MD in Credit Suisse Asset Management's institutional distribution group.
- Atlantic-Pacific Capital Adds Brian Wade as Partner
Brian Wade has joined Atlantic-Pacific Capital as a partner. Previously, Wade was a Managing Director in Credit Suisse Asset Management's institutional distribution group. Before Credit Suisse, he was the Director of Investor Relations at JLL Partners, a middle-market private equity firm.
- Atlantic-Pacific Capital Appoints Partner
Global placement agent and advisory firm Atlantic-Pacific Capital has appointed Brian Wade as partner. Wade will continue to work closely with institutional investors in the Mid-Atlantic and Southeast United States, including public and corporate pension plans, endowments, foundations, financial institutions, fund-of-funds and family offices.
- Tender Offer Commences for BioClinica
BioClinica and JLL Partners have announced that BC Acquisition Corp has commenced a tender offer for all outstanding shares of BioClinica at a price of $7.25 per share net to the seller in cash. BioClinica is a provider of clinical trial management solutions.
- Friday Letter 12 unusual months
PEO takes a look at some the year's top challenges to the industry, as well as some encouraging indicators.
- JLL Partners Buys BioClinica, JLL Partners
JLL Partners has acquired BioClinica, a provider of clinical trial management, and CoreLab Partners Inc., a provider of medical imaging and cardiac safety services. The firm will pay $7.25 a share for BioClinica, which results in an equity value of approximately $123 million. Specific terms of the CoreLab deal were not released.
- Payment Alliance Goes Up for Sale
Payment Alliance International is up for sale and expected to draw bids from middle market private equity firms, three sources say. Bank of America Merrill Lynch is advising on the auction
- New Jersey considers big secondaries offering
The state’s $70bn pension is considering selling a big chunk of its private equity portfolio to pare down relationships and potentially 'kick-start' the programme that has been mostly inactive for two years.
- Washington commits $150m to Littlejohn
Littlejohn’s fourth fund, which is targeting $1.3bn, invests in mid-market firms that are underperforming or financially distressed.